New Key Statistics Module, Z-Score and F-Score
NYSE:RMD Key Ratios
Market Cap $ M | 27,031.99 |
Enterprise Value $ M | 28,277.84 |
P/E(ttm) | 30.38 |
PE Ratio without NRI | 27.03 |
Forward PE Ratio | 23.04 |
Price/Book | 6.03 |
Price/Sales | 6.01 |
Price/Free Cash Flow | 28.73 |
Price/Owner Earnings | 31.07 |
Payout Ratio % | 0.27 |
Revenue (TTM) $ M | 4,504.00 |
EPS (TTM) $ | 6.05 |
Beneish M-Score | -2.39 |
10-y EBITDA Growth Rate % | 11.70 |
5-y EBITDA Growth Rate % | 15.20 |
y-y EBITDA Growth Rate % | 14.90 |
EV-to-EBIT | 23.27 |
EV-to-EBITDA | 19.77 |
PEG | 1.78 |
Shares Outstanding M | 147.09 |
Net Margin (%) | 19.77 |
Operating Margin % | 26.98 |
Pre-tax Margin (%) | 24.37 |
Quick Ratio | 1.89 |
Current Ratio | 3.11 |
ROA % (ttm) | 13.18 |
ROE % (ttm) | 21.68 |
ROIC % (ttm) | 16.56 |
Dividend Yield % | 1.02 |
Altman Z-Score | 9.12 |
RMD Number of Guru Trades
RMD Volume of Guru Trades
Gurus Latest Trades with NYSE:RMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RMD is held by these investors
Total 2
ResMed Inc Insider Transactions
No Available Data
News about NYSE:RMD
Total 0- 1